A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Aerial BioPharma, LLC
ClinicalTrials.gov Identifier:
NCT01681121
First received: September 5, 2012
Last updated: September 9, 2013
Last verified: September 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2013
  Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)